Protecting the maternal heart from pregnancy associated heart disease
Protecting the maternal heart from pregnancy associated heart disease
批准号:
10767091
负责人:
MICHELLE L MATTER
金额:
$35.72万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-13 至 2024-06-30
中文摘要
项目总结
英文摘要
Project Summary
Postpartum cardiomyopathy (PPCM) is a disease of unknown etiology that arises as
a complication of pregnancy in women with no prior heart disease. It occurs in
1:1800 to 1:3500 births in the United States and is characterized by an acute onset
of heart failure during the last month of pregnancy or within five months postpartum.
PPCM is a major cause of maternal morbidity and mortality with no PPCM-specific
treatment options available. During pregnancy, pregnancy-associated hypertrophy
initiates the activation of cardiomyocyte protective signaling pathways that block
stress-mediated apoptosis. In PPCM patients there is an increase in cardiomyocyte
apoptosis that leads to irreversible dysfunction and heart failure. The cellular
mechanisms driving cardiomyocyte apoptosis are not fully understood. We have
identified a gene PTRH2 (also called Bit-1) that is evolutionarily conserved, mediates
integrin regulated cell survival and apoptosis, and mutations in this gene promote
multisystem disease in humans. We hypothesize that PTRH2 is essential for
cardioprotection from peripartum stresses in the maternal heart. To study this we
developed a cardiomyocyte-specific deletion of PTRH2 (CKO). CKO male and never-
pregnant female mice demonstrate no heart defects and live to old age. However,
100% of CKO pregnant female mice develop PPCM in a dose-dependent manner
(CKO>HET). We will use cell and molecular biology and our CKO mice to determine
how PTRH2 mediates cardioprotection, test whether PTRH2 associated proteins
abrogate the PPCM phenotype in CKO pregnant mice, determine whether PTRH2
expression blocks hypertrophy and examine PPCM patient heart samples for PTRH2
gene mutations. The proposed project has the potential to identify an essential
survival pathway that is activated in pregnancy-associated hypertrophy, test PTRH2
directed therapeutic strategies in a preclinical mouse model of PPCM and determine
whether mutations in PTRH2 promote PPCM.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41420-020-00357-0
发表时间:
2020-11-12
期刊:
Cell death discovery
影响因子:
7
作者:
[Corpuz AD, Ramos JW, Matter ML]
通讯作者:
Matter ML
Measuring Mitochondrial Calcium Fluxes in Cardiomyocytes upon Mechanical Stretch-Induced Hypertrophy.
测量机械拉伸引起的心肌肥大时心肌细胞中的线粒体钙通量。
DOI:
10.1007/978-1-0716-2217-9_15
发表时间:
2022
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Ramaccini,Daniela, Giorgi,Carlotta, Matter,MichelleL]
通讯作者:
Matter,MichelleL
DOI:
10.3389/fcell.2020.624216
发表时间:
2020
期刊:
Frontiers in cell and developmental biology
影响因子:
5.5
作者:
[Ramaccini D, Montoya-Uribe V, Aan FJ, Modesti L, Potes Y, Wieckowski MR, Krga I, Glibetić M, Pinton P, Giorgi C, Matter ML]
通讯作者:
Matter ML
DOI:
10.1080/21541248.2021.1951590
发表时间:
2022-01-01
期刊:
Small GTPases
影响因子:
--
作者:
[Ghanem, Neda Z, Matter, Michelle L, Ramos, Joe W]
通讯作者:
Ramos, Joe W
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
-
批准号:10438833
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2018
-
负责人:MICHELLE L MATTER
-
依托单位:
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
-
批准号:10192771
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2018
-
负责人:MICHELLE L MATTER
-
依托单位:
Protecting the Maternal Heart From Pregnancy-Associated Heart Disease
-
批准号:9762134
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2018
-
负责人:MICHELLE L MATTER
-
依托单位:
Regulation of endothelial permeability in sepsis
-
批准号:8525409
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2012
-
负责人:MICHELLE L MATTER
-
依托单位:
Regulation of endothelial permeability in sepsis
-
批准号:8717691
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2012
-
负责人:MICHELLE L MATTER
-
依托单位:
Regulation of endothelial permeability in sepsis
-
批准号:8343175
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2012
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:8360589
-
项目类别:
-
资助金额:$45.39万
-
财政年份:2011
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:8167740
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2010
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:7959639
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2009
-
负责人:MICHELLE L MATTER
-
依托单位:
INTEGRIN-MEDIATED CELL SURVIVAL IN CARDIOVASCULAR DISEASE
-
批准号:7720343
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2008
-
负责人:MICHELLE L MATTER
-
依托单位:
THE PROTEINS RESPONSIBLE FOR INTEGRIN-MEDIATED CELL SURVIVAL
-
批准号:7609912
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2007
-
负责人:MICHELLE L MATTER
-
依托单位:
THE PROTEINS RESPONSIBLE FOR INTEGRIN-MEDIATED CELL SURVIVAL
-
批准号:7170546
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2005
-
负责人:MICHELLE L MATTER
-
依托单位:
国内基金
海外基金
果蝇Maternal Haploid 蛋白调控胚胎发育的分子机制研究
-
批准号:31460299
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2014
-
负责人:曹进国
-
依托单位:
母猪母性杀婴(maternal infanticide)行为QTL精细定位及位置候选基因研究
-
批准号:30760164
-
项目类别:地区科学基金项目
-
资助金额:18.0万元
-
批准年份:2007
-
负责人:陈从英
-
依托单位: